Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

An update on obtaining and enforcing therapeutic antibody patent claims

Therapeutic antibody patent owners face continuing challenges trying to obtain broad patents and enforce them in the United States and Europe.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Sandercock, C.G. & Storz, U. Nat. Biotechnol. 30, 615–618 (2012).

    Article  CAS  Google Scholar 

  2. Biogen Idec., Inc. and Genentech, Inc. v. GlaxoSmithKline., LLC, et al., 713 F.3d 1090 (Fed. Cir. 2013).

  3. AbbVie Deutschland GmbH & Co., et al. v. Janssen Biotech, Inc. and Centocor Biologics, LLC, 759 F.3d 1285, 1289–90, 1294 (Fed. Cir. 2014).

  4. UCB, Inc., v. Yeda Research and Development Co., Ltd., 2015 WL 4619996 at *1, 117 F.Supp.3d 755 (E.D. Va. July 15, 2015), affirmed, Appeal 2015–1957, (Fed. Cir., Sept. 8, 2016).

  5. See, Amgen, Inc. et al. v. Sanofi-Aventis U.S. LLC et al., No. 14–01317-SLR, 2016 slip op. (D. Del. March 16, 2016).

Download references


The discussion herein represents the personal views of the authors and not the views of either the authors' firms or their clients.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Ulrich Storz.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gresl, T., Storz, U. & Sandercock, C. An update on obtaining and enforcing therapeutic antibody patent claims. Nat Biotechnol 34, 1242–1244 (2016).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing